
CVC sells 16.4% stake in Cerved for €203.2m
CVC has sold a 16.4% stake in listed portfolio company Cerved Business Information, an Italian provider of business intelligence services, reaping a €203.2m return.
The placement saw Italian and international institutional investors acquire 32 million shares valued at €6.35 apiece.
Following completion of the sale the newco, Chopin, will retain a 76.7% stake in the business, equivalent to a 39.3% stake.
The divestment comes seven months after Cerved acquired an 80% stake in Recus, a debt collection business based in Treviso, for an initial consideration of €18.8m.
JP Morgan acted as bookrunner in the latest placement.
Previous funding
In June 2014, Cerved listed in Milan. The company raised proceeds of around €490m via the listing. CVC remains the majority shareholder following the flotation, which involved a free float of 43%.
Shares were originally offered at €5.00-6.60 apiece, with the final price set at the lower end of the range on €5.10, giving it a market cap of €995m.
In January 2013, CVC acquired Cerved from Bain Capital and Clessidra for €1.13bn. Credit Suisse, Deutsche Bank and HSBC provided financing for the transaction. HSBC ran the sale, which also attracted interest from Permira. Valuations for the target were close to €1bn, or 10x EBITDA, during the auction.
Bain and Clessidra acquired Cerved for €550m in December 2008 through holding company CeBi. The debt syndicate for the deal included BNP Paribas, Crédit Agricole, HSBC, IKB, Intensa Sanpaolo, MPS Banca per l'Impresa, Natixis and UniCredit.
Company
Cerved is a Milan-based provider of business intelligence services. Established in its present form between 2008-2011 through the merger of seven companies, its corporate history goes back to 1974. The company has a headcount of 1,236 and generated a turnover of €331.3m in 2014, with EBITDA of €160.1m
Advisers
Vendor – Latham & Watkins (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater